Page 2 - Takeda Development Centre Americas Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Takeda development centre americas inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Takeda Development Centre Americas Inc Today - Breaking & Trending Today

Dengue vaccine India: Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccine

Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda s goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda s existing facility in Germany and its partnership with IDT Biologika GmbH. ....

United Kingdom , Mahima Datla , Biologika Gmb , Gary Dubin , South East Asia , National Immunization Programs , National Immunization , Global Vaccine Business Unit , Western Pacific , Dengue Vaccine India , Biological E , Dengue Vaccine , Manufacturing Capacity ,

Biological E to make 50 million doses of Takeda's dengue vaccine QDENGA

India Business News: Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of deliverin ....

Andhra Pradesh , Mahima Datla , Gary Dubin , Be Limited , Biologicale Limited , Global Vaccine Business Unit , Dengue Tetravalent Vaccine , Business News , Dengue Vaccine , Biological E ,

HUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong Kong

HUTCHMED China (?HCM) announced marketing approval of ELUNATE, or fruquintinib by the Pharmacy and Poisons Board of Hong Kong for the treatment of adult patients with previously treated metastatic colorectal cancer. ....

Hong Kong , Noord Holland , Philips Electronics , China Evergrande Group , Drug Administration , Neptune Resources ,

Takeda: CHMP Recommends Approval Of HYQVIA

Takeda (TAK) announced the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of HYQVIA in patients with chronic inflammatory demyelinating polyneuropathy as maintenance therapy after stabilization with intravenous immunoglobulin therapy. ....

United States , Mark Zuckerberg , Polaris Industries Inc , Kubota Tractor Corp , European Union , Us Consumer Product Safety Commission , Motors Co , Product Safety Commission , Polaris Industries , Kubota Tractor , Michigan State , Worker Adjustment , Retraining Notification ,

Takeda Emphasizes the Need for Cross-sectoral Alliances to Address the Burden of Vector-Borne Infectious Diseases

Pti: Takeda Emphasizes the Need for Cross-sectoral Alliances to Address the Burden of Vector-Borne Infectious Diseases ....

Indian Railways , Press Trust Of India ,